Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent TaxesFinished GoodsInventoryLiabilities and Shareholders EquityLiabilities from Discontinued OperationsLiabilities from Discontinued OperationsNon-Current AssetsNon-Current DebtNotes PayablesOther Accumulated ExpensesOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Cirtran (CIRX) Common Equity (2017 - 2025)

Cirtran filings provide 14 years of Common Equity readings, the most recent being -$25.1 million for Q4 2025.

  • On a quarterly basis, Common Equity fell 2.87% to -$25.1 million in Q4 2025 year-over-year; TTM through Dec 2025 was -$25.1 million, a 2.87% decrease, with the full-year FY2025 number at -$25.1 million, down 2.87% from a year prior.
  • Common Equity hit -$25.1 million in Q4 2025 for Cirtran, up from -$25.5 million in the prior quarter.
  • In the past five years, Common Equity ranged from a high of -$21.8 million in Q4 2023 to a low of -$43.0 million in Q3 2023.
  • Median Common Equity over the past 5 years was -$40.7 million (2021), compared with a mean of -$33.7 million.
  • Biggest five-year swings in Common Equity: skyrocketed 48.23% in 2023 and later dropped 12.06% in 2024.
  • Cirtran's Common Equity stood at -$40.6 million in 2021, then dropped by 3.7% to -$42.1 million in 2022, then skyrocketed by 48.23% to -$21.8 million in 2023, then dropped by 12.06% to -$24.4 million in 2024, then decreased by 2.87% to -$25.1 million in 2025.
  • The last three reported values for Common Equity were -$25.1 million (Q4 2025), -$25.5 million (Q3 2025), and -$25.1 million (Q2 2025) per Business Quant data.